Maternal antibodies and infant immune responses to vaccines

Vaccine

Volumn 33, Issue 47, 2015, Pages 6469-6472

  Edwards, Kathryn M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Inhibition of vaccine responses; Maternal antibody; Transplacental transfer; Vaccine responses

Indexed keywords

MATERNAL ANTIBODY; VACCINE;

ARTICLE; PRIORITY JOURNAL; ANTAGONISTS AND INHIBITORS; HUMAN; IMMUNOLOGY; NEWBORN; PASSIVE IMMUNIZATION;

HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION, PASSIVE; INFANT, NEWBORN; VACCINES;

EID: 84948104374     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.07.085     Document Type: Article

References (33)

1. Kohler P.F., Farr R.S. Elevation of cord over maternal IgG immunoglobulin: evidence for an active placental IgG transport. Nature 1966, 210(June (5040)):1070-1071.
2. Niewiesk S. Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol 2014, 5:446. eCollection 2014. Review. 10.3389/fimmu.2014.00446.
3. Faucette A.N., Unger B.L., Gonik B., Chen K. Maternal vaccination: moving the science forward. Hum Reprod Update 2015, 21(January-February (1)):119-135. 10.1093/humupd/dmu041.
4. Griffin D.E., Pan C.-H. Measles: old vaccines and new vaccines. Measles - pathogenesis and control 2009, 191-212. Springer Verlag, Heidelberg. D.E. Griffin, M.B.A. Oldstone (Eds.).
5. Aaby P., Martins C.L., Garly M.L., Andersen A., Fisker A.B., Claesson M.H., et al. Measles vaccination in the presence or absence of maternal measles antibody: impact on child survival. Clin Infect Dis 2014, 59(4):484-492. 10.1093/cid/ciu354.
6. Samb B., Aaby P., Whittle H.C., Seck A.M., Rahman S., Bennett J., et al. Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal. Pediatr Infect Dis J 1995, 14:203-209. 10.1097/00006454-199503000-00007.
7. Gans H., Yasukawa L., Rinki M., Dehovitz R., Forghani B., Beeler J., et al. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. J Infect Dis 2001, 184:817-826. 10.1086/323346.
8. Gans H.A., Yasukawa L.L., Alderson A., Rinki M., Dehovitz R., Beeler J., et al. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States. J Infect Dis 2004, 190:83-90. 10.1086/421032.
9. Bertley F.M., Ibrahim S.A., Libman M., Ward B.J. Measles vaccination in the presence of maternal antibodies primes for a balanced humoral and cellular response to revaccination. Vaccine 2004, 23:444-449. 10.1016/j.vaccine.2004.06.021.
10. Njie-Jobe J., Nyamweya S., Miles D.J., Van Der Sande M., Zaman S., Touray E., et al. Immunological impact of an additional early measles vaccine in Gambian children: responses to a boost at 3 years. Vaccine 2012, 30:2543-2550. 10.1016/j.vaccine.2012.01.083.
11. Whittle H., Hanlon P., O'Neil K., Hanlon L., Marsh V., Jupp E. Trial of high-dose Edmonston-Zagreb measles vaccine in Gambia: antibody response and side-effects. Lancet 1988, 2:811-814. 10.1016/S0140-6736(88)92781-X.
12. Seng R., Samb B., Simondon F., Cisse B., Soumare M., Jensen H., et al. Increased long term mortality associated with rash after early measles vaccination in rural Senegal. Pediatr Infect Dis J 1999, 18:48-52. 10.1097/00006454-199901000-00012.
13. Garenne M., Leroy O., Beau J., Sene I. Child mortality after high titer measles vaccine: prospective study in Senegal. Lancet 1991, 338:903-907. 10.1016/0140-6736(91)91771-L.
14. Martins C., Bale C., Garly M.L., Rodrigues A., Lisse I.M., Andersen A., et al. Girls may have lower levels of maternal measles antibodies and higher risk of subclinical measles infection before the age of measles vaccination. Vaccine 2009, 27:5220-5225. 10.1016/j.vaccine.2009.06.076.
15. Borras E., Urbiztondo L., Costa J., Batalla J., Torner N., Plasencia A., et al. Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination. Epidemiol Infect 2012, 140:1599-1606. 10.1017/S0950268811002184.
16. Gans H., Dehovitz R., Forghani B., Beeler J., Maldonado Y., Arvin A.M. Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. Vaccine 2003, 21:3398-3405. 10.1016/S0264-410X(03)00341-4.
17. Oyedele O.O., Odemuyiwa S.O., Ammerlaan W., Muller C.P., Adu F.D. Passive immunity to measles in the breastmilk and cord blood of some Nigerian subjects. J Trop Pediatr 2005, 51(February (1)):45-48.
18. Szenborn L., Tischer A., Pejcz J., Rudkowski Z., Wojcik M. Passive acquired immunity against measles in infants born to naturally infected and vaccinated mothers. Med Sci Monit 2003, 9:CR541-CR546.
19. Gans H.A., Maldonado Y.A. Loss of passively acquired maternal antibodies in highly vaccinated populations: an emerging need to define the ontogeny of infant immune responses. J Infect Dis 2013, 208(July (1)):1-3. 10.1093/infdis/jit144.
20. Leineweber B., Grote V., Schaad U.B., Heininger U. Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubella and varicella-zoster virus in preterm and full term newborns. Pediatr Infect Dis J 2004, 23:361-363.
21. Leuridan E., Hens N., Hutse V., Ieven M., Aerts M., Van Damme P. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ 2010, 340:c1626.
22. Jones C., Pollock L., Barnett S.M., Battersby A., Kampmann B. The relationship between concentration of specific antibody at birth and subsequent response to primary immunization. Vaccine 2014, 32:996-1002. 10.1016/j.vaccine.2013.11.104.
23. Englund J.A., Anderson E.L., Reed G.F., Decker M.D., Edwards K.M., Pichichero M.E., et al. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 1995, 96:580-584.
24. Letson G.W., Shapiro C.N., Kuehn D., Gardea C., Welty T.K., Krause D.S., et al. Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants. J Pediatr 2004, 144(March (3)):327-332.
25. Hu Y., Wu Q., Xu B., Zhou Z., Wang Z., Zhou Y.H. Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants. Vaccine 2008, 26:6064-6067. 10.1016/j.vaccine.2008.09.014.
26. Appaiahgari M.B., Glass R., Singh S., Taneja S., Rongsen-Chandola T., Bhandari N., et al. Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants. Vaccine 2014, 32:651-656. 10.1016/j.vaccine.2013.12.017.
27. Sormunen H., Stenvik M., Eskola J., Hovi T. Age- and dose-interval-dependent antibody responses to inactivated poliovirus vaccine. J Med Virol 2001, 63:305-310. doi:10.1002/1096-9071(200104)63:4<305::AID-JMV1006>3.0.CO;2-U.
28. Warren R.J., Lepow M.L., Bartsch G.E., Robbins F.C. The relationship of maternal antibody. Pediatrics 1964, 34:4-13.
29. Daly K.A., Scott Giebink G., Lindgren B.R., Knox J., Haggerty B.J., Nordin J., et al. Maternal immunization with pneumococcal 9-valent conjugate vaccine and early infant otitis media. Vaccine 2014, 32(December (51)):6948-6955. 10.1016/j.vaccine.2014.10.060.
30. Halasa N.B., Gerber M.A., Chen Q., Wright P.F., Edwards K.M. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants. J Infect Dis 2008, 197(May (10)):1448-1454. PMID:18444800. 10.1086/587643.
31. Siegrist C.A. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 2003, 21(July (24)):3406-3412. PMID:12850349.
32. Kim D., Huey D., Oglesbee M., Niewiesk S. Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies. Blood 2011, 117(June (23)):6143-6151. PMID:21357766. 10.1182/blood-2010-11-320317.
33. Karlsson MC1, Wernersson S., Heyman B., Diaz de Ståhl T., Gustavsson S. Efficient IgG-mediated suppression of primary antibody responses in Fcgamma receptor-deficient mice. Proc Natl Acad Sci U S A 1999, 96(March (5)):2244-2249.